Creatinine clearance or radioisotope glomerular filtration rate (GFR) >=  mL/min/. m^ or a serum creatinine based on age/gender as follows:\r\n* Age: Maximum serum creatinine (mg/dL)\r\n**  to <  years: . (male) . (female)\r\n**  to <  years:  (male)  (female)\r\n**  to <  years: . (male) . (female)\r\n**  to <  years: . (male) . (female)\r\n** >=  years: . (male) . (female)
Creatinine clearance or radioisotope glomerular filtration rate (GFR) >=  mL/min/. m^ or a serum creatinine based on age/sex as follows:\r\n*  to <  years: male = .; female = .\r\n*  to <  years: male = .; female = .\r\n*  to <  years: male = ; female = \r\n*  to <  years: male = .; female = .\r\n*  to <  years: male = .; female = .\r\n* >=  years: male = .; female = .
Creatinine clearance or radioisotope glomerular filtration rate (GFR) >=  ml/min/. m^ or a serum creatinine based on age/gender as follows:\r\n* Age: maximum serum creatinine (mg/dL)\r\n*  to <  years: . (male and female) \r\n*  to <  years: . (male and female) \r\n*  to <  years:  (male and female) \r\n*  to <  years: . (male and female) \r\n*  to <  years: . (male), . (female) \r\n* >=  years: . (male), . (female)
Creatinine clearance or radioisotope glomerular filtration rate (GFR) >= ml/min/. m^ or a serum creatinine based on age/gender as follows:\r\n* Age: maximum serum creatinine (mg/dL)\r\n*  to <  years: . (male and female) \r\n*  to <  years: . (male and female) \r\n*  to <  years:  (male and female) \r\n*  to <  years: . (male and female) \r\n*  to <  years: . (male), . (female) \r\n* >=  years: . (male), . (female)
A serum creatinine based on age/gender as follows: (mg/dL)\r\n*  month to <  months male: . female: .\r\n*  months to <  year male: . female: .\r\n*  to <  years male: . female: .\r\n*  to <  years male: . female: .\r\n*  to <  years male:  female: \r\n*  to <  years male: . female: .\r\n*  to <  years: male: . female: .\r\n* >=  years male: . female: .
Creatinine clearance or radioisotope glomerular filtration rate (GFR) > mL/min/. m^ or a serum creatinine based on age/gender as follows:\r\n* Age: Maximum Serum Creatinine (mg/dL)\r\n*  to <  months: . (male) . (female)\r\n*  months to <  year: . (male) . (female)\r\n*  to <  years: . (male) . (female)\r\n*  <  years: . (male) . (female)\r\n*  to <  years: . (male) . (female)\r\n*  to <  years: . (male)\t. (female)\r\n*  to <  years: . (male)\t. (female)\r\n* >  years: . (male) . (female)
Creatinine clearance or radioisotope glomerular filtration rate (GFR) >=  mL/min/. m^ or\r\n* A serum creatinine based on age/gender as follows:\r\n** Age: maximum serum creatinine (mg/dL)\r\n**  month to <  months: . (male and female)\r\n**  months to <  year: . (male and female)\r\n**  to <  years:  (male and female)\r\n**  to <  years: . (male and female)\r\n**  to <  years:  (male and female)\r\n**  to <  years: . (male and female)\r\n**  to <  years: . (male), . (female)\r\n** >=  years: . (male), . (female)
Male or females with an age ?  years.
Serum creatinine based on age/gender; patients that do not meet the criteria but have a  hour creatinine clearance or glomerular filtration rate (GFR) (radioisotope or iothalamate) >=  mL/min/. m^ are eligible\r\n* Age: Maximum serum creatinine (mg/dL)\r\n*  to <  years: . (male and female)\r\n*  to <  years: . (male and female)\r\n*  to <  years:  (male and female)\r\n*  to <  years: . (male and female)\r\n*  to <  years: . (male) . (female)\r\n* >=  years: . (male) . (female)
Patient (male or female) ? years of age willing to agree to not father a child/become pregnant and comply with effective contraception criteria.
Female and male subjects ? years of age with one of the following:
Male or female ?  years of age.
Serum creatinine based on age/gender as follows:\r\n* Age  month to <  months; male .; female .\r\n* Age  months to <  year; male .; female .\r\n* Age  to <  years; male .; female .\r\n* Age  to <  years; male .; female .\r\n* Age  to <  years; male ; female  \r\n* Age  to <  years; male: .; female: .\r\n* Age  to <  years; male: .; female: .\r\n* Age >=  years; male: .; female: .
Male and female subjects, age >= years (at the time consent is obtained).
Male or female patient, age > years
Male or female subjects who are at least  to  years of age
Male or Female at least  years of age
Male or female subjects at least  years of age.
Male or female ?  years of age at time of consent.
Creatinine clearance or radioisotope glomerular filtration rate (GFR) >=  ml/min/. m^ or a serum creatinine based on age/gender as follows:\r\n* Age: Maximum serum creatinine (mg/dL)\r\n*  to <  years: . (male and female)\r\n*  to <  years:  (male and female)\r\n*  to <  years: . (male and female)\r\n*  to <  years: . (male) . (female)\r\n* >=  years: . (male) . (female)
Male or female patients age ?  years of age at the time of informed consent
Creatinine clearance or radioisotope glomerular filtration rate (GFR) >= mL/min/. m^ or a serum creatinine based on age/gender as follows:\r\n*  to <  years: . (male and female)\r\n*  to <  years:  (male and female)\r\n*  to <  years: . (male and female)\r\n*  to <  years: . (male) . (female)\r\n* >=  years: . (male) . (female)
Female or male ?  years of age.
Male or female, ? years of age (? years of age in Taiwan)
Creatinine clearance (CrCl) or radioisotope glomerular filtration rate (GFR) ?  mL/min/. m^ OR a serum creatinine based on age/gender as follows:\r\n*  month to <  months (male) . (female) .\r\n*  months to <  year  (male) . (female) .\r\n*  to <  years (male) . (female) .\r\n*  to <  years (male) . (female) .\r\n*  to <  years (male)  (female) \r\n*  to <  years (male) . (female) .\r\n*  to <  years (male) . (female) .\r\n* ?  years (male) . (female) .
Male or female ?  years of age
Patient (male or female) ? years of age
Male or female patients >/=  years of age with relapsed or refractory AML
Male or female patients >/=  years of age with previously untreated AML ineligible for receiving standard intensive therapy
Male or female ?  years of age
Male or female patient ?  years of age
Creatinine clearance or radioisotope glomerular filtration rate (GFR) >=  ml/min/. m^ or a serum creatinine based on age/gender as follows:\r\n*  to <  years: . (male), . (female)\r\n*  to <  years:\t. (male), . (female)\r\n*  to <  years:  (male),  (female)\r\n*  to <  years: . (male), . (female)\r\n*  to <  years: . (male), . (female)\r\n* >=  years: . (male), . (female)
Male or non-pregnant and non-lactating female, and ? years of age.
Female or male patients ? years-of-age
Creatinine clearance or radioisotope glomerular filtration rate (GFR)  mL/min/. m^ or maximum serum creatinine (mg/dL) based on age/gender as follows:\r\n* -. years, male ., female .\r\n* -. years, male ., female .\r\n* -. years, male , female \r\n* -. years, male ., female .\r\n* -. years, male ., female .\r\n* >=  years, male ., female .
A serum creatinine (mg/dL) based on age/gender as follows:\r\n* Age:  to <  years; Male: .; Female: .\r\n* Age:  to <  years; Male: ; Female: \r\n* Age:  to <  years; Male: .; Female: .\r\n* Age:  to <  years; Male:.; Female: .\r\n* Age >=  years; Male: .; Female: .
Male or female at least  years of age.
Male or female patients, ?  years of age at the time of obtaining informed consent.
STRATUM A: Creatinine clearance >=  mL/min/. m^ or serum creatinine =< the maximum serum creatinine (mg/dL) based on age/gender as listed below:\r\n*  to <  years: . (male and female)\r\n*  to <  years:  (male and female)\r\n*  to <  years: . (male and female)\r\n*  to <  years: . (male), . (female)\r\n* >=  years: . (male), . (female)
STRATUM B: Creatinine clearance >=  mL/min/. m^ or serum creatinine =< the maximum serum creatinine (mg/dL) based on age/gender as listed below:\r\n*  to <  years: . (male and female)\r\n*  to <  years:  (male and female)\r\n*  to <  years: . (male and female)\r\n*  to <  years: . (male), . (female)\r\n* >=  years: . (male), . (female)
STRATUM C: Creatinine clearance >=  mL/min/. m^ or serum creatinine =< the maximum serum creatinine (mg/dL) based on age/gender as listed below:\r\n*  to <  years: . (male and female)\r\n*  to <  years:  (male and female)\r\n*  to <  years: . (male and female)\r\n*  to <  years: . (male), . (female)\r\n* >=  years: . (male), . (female)
Male or female, ?  years of age
Subject is male or female and at least  years of age.
Female or male, age ?  years.
Male or female patients, ?  years of age at the time of obtaining informed consent.
Age > year at the time of obtaining informed consent, male or female.
Male or female subjects must be at least  years of age.
Male or female patients ? years of age.
Male and female patients ?  years of age;
Female or male patients, > years of age, able to understand and give written informed consent.
Age: Male or female age ?  years and <  years unless enrolled in Part E
CELL PROCUREMENT: Serum creatinine =< . x upper limit of normal (ULN), obtained within  hrs prior to procurement\r\n* For pediatric patients, adequate renal function is defined as below:\r\n** Age: Maximum Serum Creatinine (mg/dL)\r\n**  to <  years: =< . (male and female)\r\n**  to <  years: =<  (male and female)\r\n**  to <  years: =< . (male and female)\r\n**  to <  years: =< . (male), =< . (female)\r\n**  to <  years: =< . (male), =< . (female)
LYMPHODEPLETION: Serum creatinine =< . x ULN, obtained within  hrs prior to lymphodepletion\r\n* For pediatric patients, adequate renal function is defined as below:\r\n** Age: Maximum Serum Creatinine (mg/dL)\r\n**  to <  years: =< . (male and female)\r\n**  to <  years: =<  (male and female)\r\n**  to <  years: =< . (male and female)\r\n**  to <  years: =< . (male), =< . (female)\r\n**  to <  years: =< . (male), =< . (female)
PART  GROUP  INCLUSION CRITERIA: Creatinine clearance or radioisotope glomerular filtration rate (GFR) >=  mL/min/. m^ OR a serum creatinine based on age/gender normal as follows:\r\n*  to <  years: Male and female: .\r\n*  to <  years: Male and female: .\r\n*  to <  years: Male and female: \r\n*  to <  years: Male and female: .\r\n*  to <  years: Male: .; Female: .\r\n*  years and above: Male: .; Female: .
PART  GROUP A INCLUSION CRITERIA: Creatinine clearance or radioisotope GFR >=  mL/min/. m^ OR a serum creatinine based on age/gender normal as follows:\r\n*  to <  years: Male and female: .\r\n*  to <  years: Male and female: .\r\n*  to <  years: Male and female: \r\n*  to <  years: Male and female: .\r\n*  to <  years: Male: .; Female: .\r\n*  years and above: Male: .; Female: .
PART  GROUP  INCLUSION CRITERIA: Creatinine clearance or radioisotope GFR >=  mL/min/. m^ OR a serum creatinine based on age/gender normal as follows:\r\n*  to <  years: Male and female: .\r\n*  to <  years: Male and female: .\r\n*  to <  years: Male and female: \r\n*  to <  years: Male and female: .\r\n*  to <  years: Male: .; Female: .\r\n*  years and above: Male: .; Female: .
Male or female patients, age ? years (? years for South Korea)
PRIOR TO CELL PROCUREMENT: For patients <  years old use the following table for serum creatinine requirements:\r\n* Age (years): Maximum serum creatinine (mg/dL)\r\n*  to < : ? . (male and female)\r\n*  to < : ? . (male and female)\r\n*  to < : ? . (male and female)\r\n*  to < : ? . (male), ? . (female)\r\n* ?  and < : ? . (male), ? . (female)
PRIOR TO INFUSION OF ATLCAR.CD CELLS: For patients <  years old use the following table for serum creatinine requirements:\r\n* Age (years): Maximum serum creatinine (mg/dL)\r\n*  to < : ? . (male and female)\r\n*  to < : ? . (male and female)\r\n*  to < : ? . (male and female)\r\n*  to < : ? . (male), ? . (female)\r\n* ?  and < : ? . (male), ? . (female)
Male or female patients ?  years of age
Patients (male or female) ?  years of age.
Male or female patients ? years of age
Male >  years of age
Male or Female ?  years of age
Male or female participants age  years to less than years and less than or equal to  years for osteosarcoma subjects at the time of informed consent.
Male or female ?  years of age
Male or female patients ?  years of age
Male or female ?  years of age
Age ? years male or female.
Male or female ?  years of age.
Serum creatinine based on age or creatinine clearance or radioisotope glomerular filtration rate (GFR) >  ml/min/ml/min/. m^\r\n* Age  to <  male . female .\r\n* Age  to <  male . female .\r\n* Age  to <  male  female \r\n* Age  to <  male . female .\r\n* Age  to <  male . female .\r\n* Age >  male . female .
Male or female children, < years of age
Male or female patients ?  years of age.
Male and female patients must be at least  years of age.
Male or female patients, ?  years of age at the time of obtaining informed consent.
Be male or female at least  years of age (at the time consent is obtained);
Male or non-pregnant, non-lactating female patient at least  years of age at the time of consent;
Male or female ? years of age
Participant must be male or female at least  years of age at time of screening
Male or female age ? years old;
Male or female, Age ?  years.
Male or female patients ?  years of age.
Is a male or female ?  years of age, that has provided written informed consent.
Male or female ?  years of age;
Age > years of age; male or female.
Male or female patients, ?  years of age, able to understand and give written informed consent.
Male or female patient with age ?  years
Male or female outpatient of ?  years of age or ? country's legal age for adult consent
Male or female at least  years of age;
Male or female patients, ?  years of age at the time of obtaining informed consent.
Male or female patients, ?  years of age, able to understand and give written informed consent
Serum creatinine based on age/gender; patients that do not meet the criteria but have a  hour creatinine clearance or glomerular filtration rate (GFR) (radioisotope or iothalamate) >=  mL/min/. m^ are eligible\r\n* Age: maximum serum creatinine (mg/dL)\r\n**  to <  years: . (male and female)\r\n**  to <  years: . (male and female)\r\n**  to <  years:  (male and female)\r\n**  to <  years: . (male and female)\r\n**  to <  years: . (male) . (female)\r\n** >=  years: . (male) . (female)
Female or male subjects ? years-of-age.
A serum creatinine based on age/gender as follows:\r\n*  month to <  months: . (male) . (female)\r\n*  months to <  year: . (male), . (female)\r\n*  to <  years: . (male), . (female)\r\n*  to <  years: . (male), . (female)\r\n*  to <  years:  (male),  (female)\r\n*  to <  years: . (male), . (female)\r\n*  to <  years: . (male), . (female)\r\n* >=  years: . (male), . (female)
A serum creatinine based on age/gender as follows: maximum serum creatinine (mg/dL)\r\n*  to <  years: . (male and female)\r\n*  to <  years:  (male and female)\r\n*  to <  years: . (male and female)\r\n*  to <  years: . (male)\t. (female)\r\n*  to <  years: . (male)\t. (female)
Male or female, age ?  years
Male or female ?  years of age at Screening Visit.
Male, age  to  years
Male or female ? years of age
Male or female subjects ?  years of age
Male or female ?  years of age at time of consent
Male or female ? years of age
Male or female patients over  years of age
Male or female ?  years of age.
Female or male ? years of age
Female, age ?  years
Male or female ? years of age
Subject is male or female and at least  years of age.
Male or Female at least  years of age
Male or female patients age ?  years of age at the time of informed consent
Adult, at least  years of age, male or female
Male or female ?  years of age
Male or female ?  years of age at time of consent.
Male and female subjects; age ? 
Male subjects of age ?  years
Male or Female patients at least  years of age
Male patients >/=  years of age
Male or female patients >=  years of age
male or female patients ?  years of age.
Male or female patients >  years of age
Male or female at least  years of age.
Male ? years of age.
Female subjects with age ?  years
Male or female, at least  years of age at time of screening
Male and female ?  years of age.
Male or female patients of at least  years of age
Male or female patients ?  years of age (only female patients in breast cancer cohort of Phase ).
Male or female  years of age or over.
Male participants who are ? years of age
Age ?  years, male or female subjects.
Male or female subjects with age ?  years or the otherwise legal lower age according to the country of residence;
Subjects (male and female for Part A and female for Part B) will be at least  year of age.
Female, ? years of age
Male or female ? years of age
Male or female, at least  years of age
Age ? years (US only), and - (rest of world (ROW)), male or female.
Male or female at least  years of age
Male or female patients ?  years of age
Male and female patients at least  years of age
Male or female patients, >=  years of age at the time of obtaining informed consent.
Male or female ? years of age
Male or female >= years of age.
Male or female ? years of age.
Male or female subject ?  years of age
Male or female patients, >  years of age.
Male or female at least  years of age
Patients must be female at least  years of age.
Male and female patients from  month to less than  years of age.
Creatinine clearance OR radioisotope glomerular filtration rate >=  mL/min/.m^ or a serum creatinine based on age/gender as follows:\r\n                 Age                     Maximum Serum Creatine (mg/dL)\r\n* month to <  months          male: .  female: .\r\n*  months to < year             male: .  female: .\r\n*  year to <  years               male: .  female: .     \r\n*  to <  years                       male: .  female: .\r\n*  to <  years                     male:      female: \r\n*  to <  years                   male: .  female: .\r\n*  to <  years                   male: .  female: .\r\n* >=  years                          male: .  female: .
Male or female ? years of age at the time of informed consent
Creatinine clearance or radioisotope glomerular filtration rate (GFR) >=  mL/min/. m^ or a serum creatinine based on age/gender as follows:\r\n* Age: maximum serum creatinine (mg/dL)\r\n to <  years: . (male), . (female)\r\n to <  years: . (male), . (female)\r\n to <  years:  (male),  (female)\r\n to <  years: . (male), . (female)\r\n to <  years: . (male), . (female)\r\n>=  years: . (male), . (female)
Male or female age ? years
Female or male at least  years of age.
Female or male of at least  years of age.
Male or female, age >= years (at the time consent is obtained).
Serum creatinine at or below the upper limit of normal (ULN) for age and gender (mg/dL): \r\n*  month (mo) to <  months: male: .; female: .\r\n*  mo to <  year: male: .; female: .\r\n*  year to <  years: male: .; female: .\r\n*  to <  years: male: .; female: .\r\n*  to <  years: male: ; female: \r\n*  to <  years: male: .; female: .\r\n*  to <  years: male:.; female: .\r\n* >=  years: male: .; female: .
Female, Age ? years.
Male or female subjects at least  years of age at the time of consent;
Male or female in- or out-patient from birth to <  years at the time of randomization.
Male or female, age ?  years and ?  years. Patients aged ?  years must have a Sorror score ? 
Female age  to  years
Male or female, age ?  years and ?  years
Male or female, age ?  and ?  years (If applicable, local legal requirements for donors under the age of  will be followed)
Male or female subjects ?  and ?  years of age
Subject must be female ?  years of age
Female or male patients at least  years of age
Female over  years of age;
Male or female, age ?  years old at the time of consent.
Male or female subjects who are at least  years of age;
Male or female age ?  years at the time of informed consent
Male or female, ?  years of age.
Subjects (male or female) ?  years of age
Male or female subjects  to ?  years of age at the time of informed consent/assent.
Male or female patients ?  years of age
